IL10 and infection: But, the most common problem faced in such immunotherapies is the inhibitory effect of the IL10 protein, which is overexpressed during the infection that increases the susceptibility to the disease by inhibiting the effects of interferon-gamma treatment and often blocking the synthesis of NO [59], thereby preventing an effective anti-Leishmania immunity.